STTR Phase II: Compact Aberration Compensated Focus and Scan Control for Biomedical Sensors

这一小型企业技术转让(STTR)第二阶段项目将开发一种像差补偿焦点控制设备的商业原型。这种基于MEMS技术的设备将允许用户以受控方式偏转可变形薄膜反射镜，以便选择所需的焦距。该设备还具有主动控制低阶像差的功能。这项技术将使下一代生物医学成像设备能够在简单、紧凑和低成本的传感器中实现焦点控制和像差校正，从而应用于显微镜应用。这项研究的更广泛影响主要是生物医学成像。一家行业合作伙伴有兴趣使用该技术的像差校正功能来改进其共焦显微镜产品线中的皮肤癌检测。亚利桑那大学的显微镜和内窥镜研究人员表示，这项技术将是他们抗癌研究的宝贵财富。该公司还将与一家公认的MEMS技术领先者合作，以增强成像能力，主要用于眼科领域的成像。

This Small Business Technology Transfer (STTR) Phase II project will develop a commercial prototype of an aberration compensated focus control device. This device, based on a MEMS technology, will allow the user to deflect a deformable membrane mirror in a controlled manner in order to select a desired focal length. The device also features active control of low-order aberrations. This technology will enable the next generation of biomedical imaging devices for microscopy applications by enabling focus control and aberration correction in a simple, compact and low-cost sensor.The broader impacts of this research are primarily in biomedical imaging. An industry partner is interested in using the technologys aberration correction capabilities to improve skin cancer detection with their confocal microscopy product line. Microscopy and endomicroscopy researchers at the University of Arizona have stated that this technology will be a valuable asset in their research in the fight against cancer. The company will also team with a recognized leader in MEMS technology to enable enhanced imaging capabilities, primarily for imaging in the field of ophthalmology.